#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Congenital myopathy Glycogen storage disease type V Non-small cell lung cancer recurrent Acute lymphocytic leukaemia Arterial disorder Mixed-type liposarcoma Osteomyelitis Partial lipodystrophy Juvenile psoriatic arthritis Mitochondrial myopathy Immune-mediated myositis Metabolic disorder Small intestine leiomyosarcoma Urea cycle disorder Plasma cell myeloma More trials…

    Learn about Rare Diseases

    Niemann-Pick disease – Life with Disease Hereditary hypophosphataemic rickets – Diagnostics Pelizaeus-Merzbacher disease – Basic Information Pemphigoid – Treatment Marfan’s syndrome Ewing’s sarcoma metastatic – Diagnostics Mantle cell lymphoma – Diagnostics Hairy cell leukaemia recurrent – Trials in Disease Rosai-Dorfman syndrome Haemophilia A with anti factor VIII – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    GSK5784283 Imetelstat Sodium Naloxegol Oxalate Charcoal, Activated Vimseltinib MARALIXIBAT AAV9-CTNT-COBAG3 Cldn6 Car-T Hydroxocobalamin S-241656 Linrodostat Mesilate Pal1-15 Acetate RIMIDUCID Levamisole Hydrochloride Bexmarilimab Ondansetron Hydrochloride Eight Treg Sodium Hyaluronate Human Mesenchymal Stem Cells Clotrimazole More therapies…

    Learn about Your Condition

    Limb reduction defect Coronary artery occlusion Carcinoid tumour pulmonary Congenital myopathy Tertiary adrenal insufficiency Neuromyopathy Autism spectrum disorder Albuminuria Neurofibrosarcoma Spinal cord injury cervical HER2 positive gastric cancer Extraskeletal ossification Bronchiolitis Colorectal adenoma Hyperlipidaemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Diffuse large B-cell lymphoma

  • Study of Zilovertamab Vedotin with Drug Combination for Patients with Diffuse Large B-Cell Lymphoma

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Betamethasone Sodium Phosphate
    • Cyclophosphamide
    • Doxorubicin
    Italy Poland Spain

  • Study of Zilovertamab Vedotin with Drug Combination for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    4 1 1 1
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Gemcitabine
    • Oxaliplatin
    Denmark France Greece Italy Poland

  • Study on the Effectiveness and Safety of Glofitamab with Drug Combination for Untreated Large B-Cell Lymphoma Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • High-grade B-cell lymphoma
    • Diffuse large B-cell lymphoma
    Belgium Denmark France Germany Italy Poland +1

  • Study Comparing Axicabtagene Ciloleucel and Standard Treatment for Adults with High-Risk Large B-Cell Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Other Analgesics And Antipyretics
    • Mesna
    • Axicabtagene Ciloleucel
    Austria France Germany Italy The Netherlands Portugal +1

  • Study on the Safety and Effectiveness of Zilovertamab Vedotin for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Zilovertamab Vedotin
    Czechia Estonia France Greece Italy Norway +3

  • Study of Tazemetostat with R-CHOP for Newly Diagnosed Diffuse Large B Cell Lymphoma or High-Risk Follicular Lymphoma Patients

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    • Diffuse large B-cell lymphoma
    Investigated Drugs:
    • Tazemetostat
    • Vincristine
    • Cyclophosphamide
    Belgium France
Previous Page
1 … 6 7 8 9
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!